Science Corporation: PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes

Location: Schubert 4
Date & Time: Saturday, 3rd October, 10:15 – 11:15 CEST
Chairperson(s): F. Holz (Germany) & R. Dolz-Marco (Spain)

Speakers:

Presentations:

F. Holz (Germany)
R. Dolz-Marco (Spain)

10:15  Welcome and Clinical Context

F. Matonti (France)

10:20  From Light to Sight: How the PRIMA Implant Restores Vision in GA

F. Brodie (USA)

10:30  cutting through complexity: simplified real-world decisions with aflibercept 8mg

L. Hattenbach (Germany)

10:40  Implanting PRIMA in the Atrophic Macula: What Retinologists Need to Know

A. Cusumano (Italy)

10:50  From Subretinal Stimulation to Functional Vision: The PRIMA Rehabilitation Pathway

F. Holz (Germany)
R. Dolz-Marco (Spain)
F. Matonti (France)
F. Brodie (USA)
L. Hattenbach (Germany)
A. Cusumano (Italy)

11:00 OptimiPanel Discussion: Where Does PRIMA Go Next?

Back to Main Programme